Lenire Reviewed: Is the New Tinnitus Treatment Actually Worth It?

Lenire is the first clinically-validated bimodal neuromodulation device approved for tinnitus treatment in Europe, the UK and the US. 86% and above of suitable patients in clinical trials saw meaningful improvement after twelve weeks. Hear Now Clinic is Neuromod's NI partner. I'll explain how it works, who it suits, who it doesn't, and what twelve weeks on Lenire actually looks like.

What Lenire is

Lenire is a non-invasive medical device that treats tinnitus through bimodal neuromodulation. It consists of three parts: a small handheld controller, a tonguetip that delivers gentle electrical pulses to the tongue, and a pair of headphones that play tailored auditory stimulation. The user runs it themselves at home for one hour a day over a treatment course.

It's made by Neuromod Devices, an Irish company. It was the first device of its kind to receive a CE mark in Europe and FDA clearance in the US. Hear Now Clinic was selected as Neuromod's NI provider.

How it actually works

Tinnitus involves a brain that has become hyper-attentive to a phantom sound. Bimodal stimulation targets that attention. The auditory stimulation through the headphones and the simultaneous tactile pulses on the tongue, when paired in time, drive plasticity in the auditory cortex. Over weeks, the brain's response to the tinnitus sound is dampened.

If that sounds abstract: think of the brain as turning down the volume of a noise it had previously turned up. The treatment doesn't silence tinnitus. It reduces its perceived loudness and, more importantly, its emotional impact.

The clinical evidence

Two large clinical trials, TENT-A1 (326 patients) and TENT-A2 (191 patients), both peer-reviewed and published in Nature Scientific Reports and Frontiers in Neurology, showed:

• Approximately 70 to 80% of treatment-compliant patients showed clinically meaningful improvement

• Tinnitus Handicap Inventory scores fell by an average of 14 points (clinically meaningful is 7 or more)

• Improvements were sustained at 12-month follow-up

• No serious adverse events were reported across the trial population

That's a stronger evidence base than almost any other tinnitus intervention in the last twenty years.

Who Lenire is for

Lenire is approved for adults (18+) with chronic subjective tinnitus. It works best for patients who:

• Have had tinnitus for more than three months

• Find their tinnitus distressing (we measure this with a Tinnitus Handicap Inventory)

• Don't have an unstable medical cause for the tinnitus

• Are willing to commit to X2 30minute sessions a day at home for 12 weeks

We screen carefully at the initial assessment to identify the patients most likely to respond.

Who it's not for

Lenire isn't right for everyone. Reasons we wouldn't recommend it include but arent limited to:

• Pulsatile tinnitus (different mechanism, needs ENT investigation)

• Tinnitus less than three months old (often resolves on its own)

• Active middle-ear pathology

• Cochlear implants or active brain implants

• Pregnancy

What the 12 weeks looks like

Weeks 1-2: Setup

Initial assessment (90 minutes). Full audiogram, tinnitus characterisation, screening. Device fitting. We set the audio stimulation parameters and show you how to use it. You'll go home with the device and a clear routine adn will be cehcked up on at the 2 week mark.

Weeks 3-6: Stage 1 treatment

You sit comfortably at home, place the Tonguetip in your mouth, put the headphones on, start the session. At the 6 week mark you'll come back for a review and we adjust if needed.

Weeks 7-12: Stage 2 treatment

We modify the stimulation parameters based on your response. Same daily routine. Another review at 12 weeks to measure outcomes.

Weeks 13-26: Maintenance and follow-up

Most patients reach their best outcome by 12 weeks. We provide review appointments and the device for an additional period to support consolidation. Total package is 6 months. We also discuss tapering off the treatments from 12 weeks.

Cost

At Hear Now Clinic, a full 6-month Lenire treatment is £3,600. That includes:

• Initial 90-minute tinnitus assessment

• Lenire device for the full 6 months

• Fitting and programming

• Mid-stage review and adjustment

• 12-week outcome review

• All follow-up appointments through the 6 months

• Direct support throughout

It isn't available on the NHS in NI. Some private health insurance policies will partially reimburse. Check your policy.

What patients tell me

Reactions vary. Some patients describe a clear, noticeable change within 4 to 6 weeks. Some experience a slower drift downwards in awareness across the 12 weeks.

The best results I've seen are in patients with moderate to severe-distress tinnitus . We often pair Lenire with appropriate hearing aids, and the combination outperforms either alone.

Is it worth £3,600?

If your tinnitus is significantly affecting your sleep, your work or your mood, and the cheaper interventions (sound therapy, treating any hearing loss, CBT) haven't been enough, then yes, for most suitable patients, it's worth it. The evidence base is the strongest in the tinnitus field and the protocol is rigorous.

Frequently asked questions

Does Lenire cure tinnitus? No, and Neuromod is careful never to claim that. It reduces tinnitus impact and loudness for the majority of suitable patients. Some experience near-resolution, many experience meaningful relief.

How long do the effects last? Clinical trials showed sustained improvement at 12 months. Some patients may benefit from refresher sessions later. Our 6-month package supports consolidation.

Is Lenire safe? Yes. It's a CE-marked and FDA-approved device. No serious adverse events were recorded across the trial population with 10,000 devices having been dispensed globally. Tongue tingling during use is normal.

Do I have to come into the clinic every day? No. After the initial setup, you use Lenire at home for one hour a day. You come in for the mid-stage review (around week 6) and the 12-week outcome assessment.

Can I combine Lenire with hearing aids? Yes, and in many cases the combination outperforms either alone. If you have hearing loss, we'll discuss how to integrate aids into the treatment plan.

Why isn't Lenire on the NHS? It's not currently NHS-commissioned in NI. Private routes are the only option. We're Neuromod's NI partner, so the full care pathway is delivered here.